摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-bromo-2-nitrophenyl)ethanol | 856839-64-0

中文名称
——
中文别名
——
英文名称
2-(4-bromo-2-nitrophenyl)ethanol
英文别名
——
2-(4-bromo-2-nitrophenyl)ethanol化学式
CAS
856839-64-0
化学式
C8H8BrNO3
mdl
——
分子量
246.06
InChiKey
IXOSFCCRVSYFCK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    341.5±27.0 °C(Predicted)
  • 密度:
    1.665±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    66
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(4-bromo-2-nitrophenyl)ethanol 在 C30H29BrMnNO2P2potassium tert-butylate氢气potassium carbonate 作用下, 以 甲苯 为溶剂, 120.0~130.0 ℃ 、8.0 MPa 条件下, 反应 48.0h, 生成 6-溴吲哚
    参考文献:
    名称:
    Dehydrogenative and Redox-Neutral N-Heterocyclization of Aminoalcohols Catalyzed by Manganese Pincer Complexes
    摘要:
    DOI:
    10.1021/acs.organomet.2c00027
  • 作为产物:
    描述:
    4-bromo-2-nitrophenethyl acetate 在 、 sodium hydroxide 、 盐酸氯化铵 作用下, 以 甲醇 为溶剂, 反应 2.0h, 以83%的产率得到2-(4-bromo-2-nitrophenyl)ethanol
    参考文献:
    名称:
    EP2151447
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • [EN] AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION<br/>[FR] AMINOBENZIMIDAZOLES ET BENZIMIDAZOLES UTILISES EN TANT QU'INHIBITEURS DE LA REPLICATION DU VIRUS SYNCYTIAL RESPIRATOIRE
    申请人:TIBOTEC PHARM LTD
    公开号:WO2005058869A1
    公开(公告)日:2005-06-30
    Aminobenzimidazoles and benzimidazoles having inhibitory activity on RSV replication and having the formula (I) the prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof; wherein G is a direct bond or C1-10alkanediyl optionally substituted with one or more hydroxy, C1-6alkyloxy, Ar1Cl-6alkyloxy, C1-6alkylthio, Ar1C1-6alkylthio, HO(-CH2-CH2-O)n-, C1-6alkyloxy(-CH2-M2-O)n- or Ar1Cl-6alkyloxy(-CH2-C2-O)n-; R1 is Ar1 or a monocyclic or bicyclic heterocycle; Q is hydrogen, amino or mono- or di(C1-4alkyl)amino; one of R2a and R3a is selected from halo, optionally mono- or polysubstituted C1-6alkyl, optionally mono- or polysubstituted C2-6alkenyl, nitro, hydroxy, Ar2, N(R4aR4b), N(R4aR4b)sulfonyl, N(R4aR4b)carbonyl, C1-6alkyloxy, Ar2oxy, Ar2C1-6alkyloxy, carboxyl, C1-6alkyloxycarbonyl, or -C(=Z)Ar2; and the other one of R2a and R3a is hydrogen; in case R2a is different from hydrogen then R2b is hydrogen, C1-6alkyl or halogen and R3b is hydrogen; in case R3a is different from hydrogen then R3b is hydrogen, C1-6alkyl or halogen and R2b is hydrogen. Compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.
    氨基苯并咪唑和对RSV复制具有抑制活性的苯并咪唑,其具有式(I)的前药、N-氧化物、加合盐、季铵盐、金属配合物和立体化学异构体形式;其中G是直接键或C1-10烷二基,可选地取代一个或多个羟基、C1-6烷氧基、Ar1Cl-6烷氧基、C1-6烷基硫氧基、Ar1C1-6烷基硫氧基、HO(-CH2-CH2-O)n-、C1-6烷氧基(-CH2-M2-O)n-或Ar1Cl-6烷氧基(-CH2-C2-O)n-;R1是Ar1或单环或双环杂环;Q是氢、氨基或单或双(C1-4烷基)氨基;R2a和R3a中的一个选择自卤素、可选地单或多取代的C1-6烷基、可选地单或多取代的C2-6烯基、硝基、羟基、Ar2、N(R4aR4b)、N(R4aR4b)磺酰基、N(R4aR4b)羰基、C1-6烷氧基、Ar2氧基、Ar2C1-6烷氧基、羧基、C1-6烷氧羰基或-C(=Z)Ar2;R2a和R3a中的另一个是氢;如果R2a不同于氢,则R2b是氢、C1-6烷基或卤素,而R3b是氢;如果R3a不同于氢,则R3b是氢、C1-6烷基或卤素,而R2b是氢。含有这些化合物作为活性成分的组合物以及制备这些化合物和组合物的方法。
  • Enantioselective Copper-Catalyzed Intramolecular N−H Bond Insertion: Synthesis of Chiral 2-Carboxytetrahydroquinolines
    作者:Xiao-Guang Song、Yuan-Yuan Ren、Shou-Fei Zhu、Qi-Lin Zhou
    DOI:10.1002/adsc.201600390
    日期:2016.7.28
    realized by using copper catalysts modified with chiral spirobisoxazoline ligands, which provides a novel strategy for the synthesis of chiral 2‐carboxytetrahydroquinolines. This reaction features fast reaction rate, high yield, high enantioselectivity, and mild reaction conditions.
    通过使用经手性螺双二恶唑啉配体改性的铜催化剂,实现了第一个高度对映选择性的分子内NH键插入,这为手性2-羧基四氢喹啉的合成提供了新的策略。该反应具有反应速度快,产率高,对映选择性高和反应条件温和的特点。
  • Synthesis of Indolines via a SmI<sub>2</sub>Promoted Domino Nitro Reduction-Intramolecular<i>aza</i>-Michael Reaction
    作者:Josierika A. Ferreira Ramos、Carolina S. Araújo、Tanus J. Nagem、Jason G. Taylor
    DOI:10.1002/jhet.1982
    日期:2015.1
    straightforward synthesis of substituted indolines based on a domino nitro reduction intramolecular aza‐Michael reaction is described. The reaction employs Samarium diiodide under mild conditions for the addition of dibromoacetic acid to substituted 2‐(2‐nitrophenyl) acetaldehyde derivatives and their subsequent cyclization upon nitro group reduction to provide corresponding indoline heterocycles in good yields
    描述了基于多米诺硝基还原分子内氮杂-Michael反应的简单直接合成取代的二氢吲哚。该反应在温和的条件下使用二碘化Sa,将二溴乙酸添加到取代的2-(2-硝基苯基)乙醛衍生物中,然后在硝基还原后将其环化,以高收率提供相应的二氢吲哚杂环。这种“一锅”策略还允许快速合成1,2,3,4-四氢喹啉,而在这些反应条件下未形成七元2,3,4,5-四氢苯并a庚因化合物。
  • [EN] MORPHOLINYL CONTAINING BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION<br/>[FR] BENZIMIDAZOLES CONTENANT DU MORPHOLINYLE EN TANT QU'INHIBITEURS DE LA REPLICATION DU VIRUS RESPIRATOIRE SYNCYTIAL
    申请人:TIBOTEC PHARM LTD
    公开号:WO2005058871A1
    公开(公告)日:2005-06-30
    The present invention concerns morpholinyl containing benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula (I), a prodrug, N-oxide, addition salt, quaternary amine, metal complex or stereochemically isomeric form thereof wherein G is a direct bond or optionally substituted C1-10alkanediyl; Rl is Ar1 or a monocyclic or bicyclic heterocycle Q is R7, pyrrolidinyl substituted with R7, piperidinyl substituted with R7 or homopiperidinyl substituted with R7; one of R2a and R3a is selected from halo, optionally mono- or polysubstituted Cl-6alkyl, optionally mono- or polysubstituted C2-6alkenyl, nitro, hydroxy, Ar2, N(R4aR4), N(R4aR4)sulfonyl, N(R4aR4b)carbonyl, C1-6alkyloxy, Ar2oxy, Ar2Cl-6alkyloxy, carboxyl, Cl-6alkyloxycarbonyl, or -C(=Z)Ar2; and the other one of R2a and R3a is hydrogen; in case R2a is different from hydrogen then R2b is hydrogen, C1-6alkyl or halogen and R3b is hydrogen; in case R3a is different from hydrogen then R3b is hydrogen, C1-6alkyl or halogen and R2b is hydrogen. It further concerns the preparation thereof and compositions comprising these compounds, as well as the use thereof as a medicine.
    本发明涉及含有对呼吸道合胞病毒复制具有抑制活性的吗啉基苯并咪唑的化合物,其具有式(I),一种前药、N-氧化物、加合盐、季铵盐、金属配合物或其立体化异构体,其中G是直键或可选择地取代的C1-10烷二基;R1是Ar1或单环或双环杂环;Q是R7,R7取代的吡咯烷基、R7取代的哌啶基或R7取代的同构异哌啶基;R2a和R3a中的一个选自卤素、可选择单取代或多取代的Cl-6烷基、可选择单取代或多取代的C2-6烯基、硝基、羟基、Ar2、N(R4aR4)、N(R4aR4)磺酰基、N(R4aR4b)羰基、C1-6烷氧基、Ar2氧基、Ar2Cl-6烷氧基、羧基、Cl-6烷氧羰基或-C(=Z)Ar2;R2a和R3a中的另一个是氢;如果R2a与氢不同,则R2b是氢、C1-6烷基或卤素,R3b是氢;如果R3a与氢不同,则R3b是氢、C1-6烷基或卤素,R2b是氢。还涉及其制备以及包含这些化合物的组合物,以及其作为药物的用途。
  • Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
    申请人:Bonfanti Jean-Francois
    公开号:US20070099924A1
    公开(公告)日:2007-05-03
    Aminobenzimidazoles and benzimidazoles having inhibitory activity on RSV replication and having the formula the prodrugs, N-oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms thereof, wherein G is a direct bond or C 1-10 alkanediyl optionally substituted with one or more hydroxy, C 1-6 alkyloxy, Ar 1 C 1-6 alkyloxy, C 1-6 alkylthio, Ar 1 C 1-6 alkylthio, HO(—CH 2 —CH 2 —O) n —, C 1-6 alkyloxy(—CH 2 —CH 2 —O) n — or Ar 1 C 1-6 alkyloxy(—CH 2 —CH 2 —O) n —; R 1 is Ar 1 or a monocyclic or bicyclic heterocycle; Q is hydrogen, amino or mono- or di(C 1-4 alkyl)amino; one of R 2a and R 3a is selected from halo, optionally mono- or polysubstituted C 1-6 alkyl, optionally mono- or polysubstituted C 2-6 alkenyl, nitro, hydroxy, Ar 2 , N(R 4a R 4b ), N(R 4a R 4b )sulfonyl, N(R 4a R 4b )carbonyl, C 1-6 alkyloxy, Ar 2 oxy, Ar 2 C 1-6 alkyloxy, carboxyl, C 1-6 alkyloxycarbonyl, or —C(═Z)Ar 2 ; and the other one of R 2a and R 3a is hydrogen; in case R 2a is different from hydrogen then R 2b is hydrogen, C 1-6 alkyl or halogen and R 3b is hydrogen; in case R 3a is different from hydrogen then R 3b is hydrogen, C 1-6 alkyl or halogen and R 2b is hydrogen. Compositions containg these compounds as active ingredient and processes for preparing these compounds and compositions.
    具有RSV复制抑制活性的氨基苯并咪唑和苯并咪唑,其具有以下公式的前药,N-氧化物,加成盐,季铵盐,金属配合物和立体化学异构体形式,其中G是直接键或C1-10烷二基,可选地取代一个或多个羟基,C1-6烷氧基,Ar1C1-6烷氧基,C1-6烷基硫基,Ar1C1-6烷基硫基,HO(-CH2-CH2-O)n-,C1-6烷氧基(-CH2-CH2-O)n-或Ar1C1-6烷氧基(-CH2-CH2-O)n-; R1是Ar1或单环或双环杂环; Q是氢,氨基或单或双(C1-4烷基)氨基之一; R2a和R3a中的一个选自卤素,可选择单或多取代的C1-6烷基,可选择单或多取代的C2-6烯基,硝基,羟基,Ar2,N(R4aR4b),N(R4aR4b)磺酰基,N(R4aR4b)羰基,C1-6烷氧基,Ar2氧基,Ar2C1-6烷氧基,羧基,C1-6烷氧羰基或-C(═Z)Ar2; R2a和R3a中的另一个是氢; 在R2a不同于氢的情况下,R2b是氢,C1-6烷基或卤素,而R3b是氢; 在R3a不同于氢的情况下,R3b是氢,C1-6烷基或卤素,而R2b是氢。含有这些化合物作为活性成分的组合物以及制备这些化合物和组合物的过程。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐